Page last updated: 2024-10-20

pyrazinamide and Central Nervous System Origin Vertigo

pyrazinamide has been researched along with Central Nervous System Origin Vertigo in 3 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
TANI, P1
POPPIUS, H1
BEK, E1
Bialik, IB1

Other Studies

3 other studies available for pyrazinamide and Central Nervous System Origin Vertigo

ArticleYear
SIDE EFFECTS OF AN ANTITUBERCULOUS FIVE-DRUG REGIMEN: ETHIONAMIDE, CYCLOSERINE, PYRAZINAMIDE, VIOMYCIN AND ISONIAZID.
    Acta tuberculosea et pneumologica Scandinavica, 1963, Volume: 43

    Topics: Amyloidosis; Antitubercular Agents; Cycloserine; Deafness; Drug Hypersensitivity; Duodenal Ulcer; Et

1963
[INTOLERANCE AND TOXICITY OF SUBSTITUTE ANTIBACTERIAL DRUGS].
    Gruzlica (Warsaw, Poland : 1926), 1963, Volume: 31

    Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anti-Bacterial Agents; Chemical and Drug Induced Liver In

1963
[Kanamycin and florimycin in the clinical course of pulmonary tuberculosis].
    Antibiotiki, 1971, Volume: 16, Issue:2

    Topics: Adolescent; Adult; Albuminuria; Aminosalicylic Acids; Antitubercular Agents; Chronic Disease; Cyclos

1971